| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 23,610 | 27,460 | 10,460 | 28,650 | 13,290 |
| Sales Growth | -14.02% | +162.52% | -63.49% | +115.58% | +3.50% |
| Net Income | -105,510 | -46,050 | -41,540 | -8,560 | -12,760 |
| Net Income Growth | -129.12% | -10.86% | -385.28% | +32.92% | +47.96% |
Zevra Therapeutics Inc (ZVRA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.01 unch (unch) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.01 unch (unch) 16:22 ET
for Fri, Mar 21st, 2025
Zevra Therapeutics is a rare disease company melding science, data, and patient need to create transformational therapies for diseases with limited or no treatment options. Zevra Therapeutics, formerly known as KemPharm Inc., is based in CELEBRATION, Fla.
Fiscal Year End Date: 12/31